KFDA to Revise Regulations on Biological Drugs

In an effort to bring the level of current regulations surrounding review and approval for use of current and future biological drugs to advanced international standards, the Korea Food and Drug Administration (KFDA) announced its plans to make significant revisions to existing guidelines, ultimately to achieve an elevated measure in safety control and management.

To reflect the above commit...